Response to Comment on Meek et al. Reappearance of C-Peptide During the Third Trimester in Type 1 Diabetes Pregnancy: Pancreatic Regeneration or Fetal Hyperinsulinism? Diabetes Care 2021;44:1826-1834

Claire L Meek^{1

2

3}, Richard A Oram⁴, Timothy J McDonald^{4

5}, Denice S Feig^{6

7}, Andrew T Hattersley⁴, Helen R Murphy^{2

8

9}

Affiliations

¹ The Wellcome Trust-MRC Institute of Metabolic Science, Metabolic Research Laboratories, University of Cambridge, Addenbrooke's Hospital, Cambridge, U.K.
² Wolfson Diabetes and Endocrinology Clinic, Cambridge University Hospitals, Addenbrooke's Hospital, Cambridge, U.K.
³ Department of Clinical Biochemistry, Cambridge University Hospitals, Addenbrooke's Hospital, Cambridge, U.K.
⁴ Department of Diabetes Research, University of Exeter, Royal Devon and Exeter Hospital, Exeter, U.K.
⁵ Academic Department of Blood Sciences, Royal Devon and Exeter NHS Foundation Trust, Exeter, U.K.
⁶ Leadership Sinai Centre for Diabetes, Mount Sinai Hospital, Department of Medicine, University of Toronto, Toronto, Canada.
⁷ Lunenfeld-Tanenbaum Research Institute, Toronto, Canada.
⁸ Department of Women and Children's Health, King's College London, St. Thomas' Hospital, London, U.K.
⁹ Norwich Medical School, Faculty of Medicine and Health Sciences, University of East Anglia, Norwich, U.K.

Comment

Claire L Meek et al. Diabetes Care. 2022.

. 2022 Feb 1;45(2):e43-e44.

doi: 10.2337/dci21-0054.

Claire L Meek^{1

2

3}, Richard A Oram⁴, Timothy J McDonald^{4

5}, Denice S Feig^{6

7}, Andrew T Hattersley⁴, Helen R Murphy^{2

8

9}

¹ The Wellcome Trust-MRC Institute of Metabolic Science, Metabolic Research Laboratories, University of Cambridge, Addenbrooke's Hospital, Cambridge, U.K.
² Wolfson Diabetes and Endocrinology Clinic, Cambridge University Hospitals, Addenbrooke's Hospital, Cambridge, U.K.
³ Department of Clinical Biochemistry, Cambridge University Hospitals, Addenbrooke's Hospital, Cambridge, U.K.
⁴ Department of Diabetes Research, University of Exeter, Royal Devon and Exeter Hospital, Exeter, U.K.
⁵ Academic Department of Blood Sciences, Royal Devon and Exeter NHS Foundation Trust, Exeter, U.K.
⁶ Leadership Sinai Centre for Diabetes, Mount Sinai Hospital, Department of Medicine, University of Toronto, Toronto, Canada.
⁷ Lunenfeld-Tanenbaum Research Institute, Toronto, Canada.
⁸ Department of Women and Children's Health, King's College London, St. Thomas' Hospital, London, U.K.
⁹ Norwich Medical School, Faculty of Medicine and Health Sciences, University of East Anglia, Norwich, U.K.

No abstract available

Comment on

Reappearance of C-Peptide During the Third Trimester of Pregnancy in Type 1 Diabetes: Pancreatic Regeneration or Fetal Hyperinsulinism?
Meek CL, Oram RA, McDonald TJ, Feig DS, Hattersley AT, Murphy HR; CONCEPTT Collaborative Group. Meek CL, et al. Diabetes Care. 2021 Aug;44(8):1826-1834. doi: 10.2337/dc21-0028. Epub 2021 Jun 26. Diabetes Care. 2021. PMID: 34175829
Comment on Meek et al. Reappearance of C-Peptide During the Third Trimester of Pregnancy in Type 1 Diabetes: Pancreatic Regeneration or Fetal Hyperinsulinism? Diabetes Care 2021;44:1826-1834.
Ivanisevic M, Djelmis J. Ivanisevic M, et al. Diabetes Care. 2022 Feb 1;45(2):e41-e42. doi: 10.2337/dc21-2072. Diabetes Care. 2022. PMID: 35050368 Free PMC article. No abstract available.